Unlocking the mysteries of cryptogenic stroke: the role of long-term cardiac rhythm monitoring

Click to increase image sizeClick to decrease image size

Financial disclosure

The author has no financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

Competing interests disclosure

PE Papakonstantinou reports consultancy for Boehringer Ingelheim and was an investigator in the Bayer-sponsored OCEANIC-AF study.

Writing disclosure

No writing assistance was utilized in the production of this manuscript.